|
Notification regarding unquoted securities - CYP
|
30 June 2023 at 1:40pm
|
|
Proposed issue of securities - CYP
|
30 June 2023 at 10:10am
|
|
Cynata announces CEO succession and Board changes
|
30 June 2023 at 9:35am
|
|
Change in substantial holding
|
15 June 2023 at 8:45am
|
|
Appendix 3Ys x 6
|
1 June 2023 at 4:45pm
|
|
Top 20 Listed Optionholders & Distribution Schedule
|
1 June 2023 at 10:15am
|
|
Application for quotation of securities - CYP
|
1 June 2023 at 10:15am
|
|
Cleansing Notice
|
31 May 2023 at 1:25pm
|
|
Application for quotation of securities - CYP
|
31 May 2023 at 1:20pm
|
|
Results of Meeting
|
25 May 2023 at 11:30am
|
|
Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT
|
22 May 2023 at 10:50am
|
|
Application for quotation of securities - CYP
|
11 May 2023 at 10:20am
|
|
Cynata Completes Oversubscribed Share Purchase Plan
|
10 May 2023 at 1:20pm
|
|
Quarterly Activity Report & Appendix 4C
|
28 April 2023 at 1:15pm
|
|
Proposed issue of securities - CYP
|
24 April 2023 at 12:40pm
|
|
Letter to Shareholders, Notice of Meeting & Proxy Form
|
24 April 2023 at 11:15am
|
|
Cleansing Notice
|
24 April 2023 at 10:05am
|
|
Application for quotation of securities - CYP
|
24 April 2023 at 10:05am
|
|
Target Market Determination
|
19 April 2023 at 4:55pm
|
|
Share Purchase Plan Booklet & Option Prospectus
|
19 April 2023 at 4:10pm
|
|
Cleansing Notice
|
17 April 2023 at 9:50am
|
|
Application for quotation of securities - CYP
|
17 April 2023 at 9:50am
|
|
Ethics Committee Approval for Proposed aGvHD Phase 2 Trial
|
12 April 2023 at 10:05am
|
|
Capital Raising Presentation
|
6 April 2023 at 9:50am
|
|
Proposed issue of securities - CYP
|
6 April 2023 at 9:50am
|
|
Cynata completes $5.0m Placement and launches SPP
|
6 April 2023 at 9:50am
|
|
Trading Halt
|
4 April 2023 at 9:45am
|
|
Notification of cessation of securities - CYP
|
3 April 2023 at 6:10pm
|
|
Cynata Adds New Sites for DFU Clinical Trial
|
16 March 2023 at 1:55pm
|
|
Appendix 4D & Half-Year Financial Statements
|
28 February 2023 at 3:35pm
|
|
Notification of cessation of securities - CYP
|
6 February 2023 at 6:05pm
|
|
Quarterly Activity Report & Appendix 4C
|
31 January 2023 at 1:55pm
|
|
Cynata Receives IRB Approval for aGvHD Clinical Trial
|
30 January 2023 at 9:30am
|
|
Notice of Acceptance for Cynata Australian Patent
|
9 January 2023 at 1:10pm
|
|
Notification of cessation of securities - CYP
|
5 January 2023 at 5:55pm
|
|
Cynata Receives $1.65m R&D Tax Incentive Refund
|
5 December 2022 at 9:25am
|
|
Appendix 3Y - Janine Rolfe
|
23 November 2022 at 11:45am
|
|
Notification regarding unquoted securities - CYP
|
23 November 2022 at 11:45am
|
|
Results of AGM
|
22 November 2022 at 1:20pm
|
|
AGM Presentations
|
22 November 2022 at 9:15am
|
|
Conference Data Demonstrating Consistency of Cynata MSCs
|
16 November 2022 at 9:25am
|
|
Notice of Allowance for Cynata US Patent
|
11 November 2022 at 9:40am
|
|
Notification of cessation of securities - CYP
|
7 November 2022 at 5:20pm
|
|
New Kidney Transplantation Clinical Trial for Cynata & LUMC
|
2 November 2022 at 9:35am
|
|
Quarterly Activity Report & Appendix 4C
|
31 October 2022 at 4:59pm
|
|
Annual Report to Shareholders
|
21 October 2022 at 5:20pm
|
|
Letter to Shareholders, Notice of AGM & Proxy Form
|
21 October 2022 at 5:10pm
|
|
Notice of Allowance for Australia & Canada Cymerus Patents
|
17 October 2022 at 9:55am
|
|
Successful Completion of Planned DSMB Review of DFU Trial
|
12 October 2022 at 9:50am
|
|
Date of AGM and Closing Date for Director Nominations
|
27 September 2022 at 9:15am
|
Cynata Therapeutics